PARI Pharma GmbH

We've been pioneering healthcare improvements for over 100 years, and have built a reputation for delivering innovation and quality. Guided by a world-class research lab, we develop products that continually advance the science of respiratory care.

Welcome to PARI Pharma!
The future of effective aerosol therapies lies in the optimization of drug-to-device and device-to-drug. PARI Pharma has taken the next step and combined formulation development, next generation aerosol platforms, and aerosol characterization under one roof.
We are currently working with both the eFlow® Technology (lower respiratory) and Vibrent® Technology (upper respiratory) Advanced Aerosol Delivery platforms.
This multifunctional development program is the key to creating targeted therapies with high deposition amounts, low side-effect profiles, improved patient compliance…and better controlled, healthier patients.

Details


Adresse:
PARI Pharma GmbH

Moosstrasse 3
82319 Starnberg
Deutschland
Arbeitsgebiet:
Klinik & Praxis
Sonstige Tätigkeitsfelder
Expansion:
international
Mitarbeiteranzahl:
51-500